Clinical Trial Update: A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A randomized double-blind study assessing N-acetyl cysteine for prevention and treatment of hypoglycemia unawareness in type 1 diabetes (phases 1 and 2). Comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: University of Minnesota | Conditions: Type 1 Diabetes, Hypoglycemia Unawareness | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-31